These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9112504)

  • 1. Corporeal veno-occlusive dysfunction: predominantly intracavernous muscular pathology.
    Wespes E; Sattar AA; Golzarian J; Wery D; Daoud N; Schulman CC
    J Urol; 1997 May; 157(5):1678-80. PubMed ID: 9112504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse veno-occlusive dysfunction: the underlying hemodynamic abnormality resulting in failure to respond to intracavernous pharmacotherapy.
    Martins FE; Padma-Nathan H
    J Urol; 1996 Dec; 156(6):1942-6. PubMed ID: 8911361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo assessment of trabecular smooth muscle tone, its application in pharmaco-cavernosometry and analysis of intracavernous pressure determinants.
    Hatzichristou DG; Saenz de Tejada I; Kupferman S; Namburi S; Pescatori ES; Udelson D; Goldstein I
    J Urol; 1995 Apr; 153(4):1126-35. PubMed ID: 7869480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic characterization of a functional erection. Arterial and corporeal veno-occlusive function in patients with a positive intracavernosal injection test.
    Hatzichristou DG; Hatzimouratidis K; Apostolidis A; Ioannidis E; Yannakoyorgos K; Kalinderis A
    Eur Urol; 1999; 36(1):60-7. PubMed ID: 10364657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure.
    Nehra A; Goldstein I; Pabby A; Nugent M; Huang YH; de las Morenas A; Krane RJ; Udelson D; Saenz de Tejada I; Moreland RB
    J Urol; 1996 Oct; 156(4):1320-9. PubMed ID: 8808863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of arterial inflow by gravity cavernosometry.
    De Meyer JM; Thibo P; Oosterlinck W
    J Urol; 1997 Aug; 158(2):440-3. PubMed ID: 9224319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the accuracy of vascular testing in impotent men: correcting hemodynamic alterations using a vasoactive medication re-dosing schedule.
    Mulhall JP; Abdel-Moneim A; Abobakr R; Goldstein I
    J Urol; 2001 Sep; 166(3):923-6. PubMed ID: 11490247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corporeal veno-occlusive dysfunction: a distal arterial pathology?
    Wespes E; Raviv G; Vanegas JP; Decaestecker C; Petein M; Danguy A; Schulman CC; Kiss R
    J Urol; 1998 Dec; 160(6 Pt 1):2054-7. PubMed ID: 9817322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could standardized cavernosometry be helpful in therapeutic management of veno-occlusive dysfunction?
    Sasso F; Gulino G; Basar M; Alcini A; Alcini E
    J Urol; 1996 Jan; 155(1):150-4. PubMed ID: 7490818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The resistance index represents the corporeal pressure and not the cavernous wall resistance.
    de Meyer JM; Thibo P
    J Urol; 1997 Mar; 157(3):830-2. PubMed ID: 9072579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vacuum therapy prevents corporeal veno-occlusive dysfunction and penile shrinkage in a cavernosal nerve injured rat model.
    Qian SQ; Qin F; Zhang S; Yang Y; Wei Q; Wang R; Yuan JH
    Asian J Androl; 2020; 22(3):274-279. PubMed ID: 31249269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient selection criteria in the surgical treatment of veno-occlusive dysfunction.
    Sasso F; Gulino G; Weir J; Viggiano AM; Alcini E
    J Urol; 1999 Apr; 161(4):1145-7. PubMed ID: 10081857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cavernosal ischemia and corporal veno-occlusive dysfunction in an animal model.
    Azadzoi KM; Park K; Andry C; Goldstein I; Siroky MB
    J Urol; 1997 Mar; 157(3):1011-7. PubMed ID: 9072535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A histopathological study of deep dorsal penile vein in venogenic impotence.
    Claes H; Van de Voorde W; Vandeginste S; Gnanasakthy A; Van Poppel H; Baert L; Lauweryns J
    Acta Urol Belg; 1994 Dec; 62(4):61-7. PubMed ID: 7793351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to attain stretched penile length after intracavernosal injection of a vasodilator agent is predictive of veno-occlusive dysfunction on penile duplex Doppler ultrasonography.
    Yafi FA; Libby RP; McCaslin IR; Sangkum P; Sikka SC; Hellstrom WJ
    Andrology; 2015 Sep; 3(5):919-23. PubMed ID: 26235901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction.
    Montorsi F; Guazzoni G; Bergamaschi F; Ferini-Strambi L; Barbieri L; Rigatti P
    J Urol; 1993 May; 149(5 Pt 2):1291-5. PubMed ID: 7683061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penile blunt trauma induced veno-occlusive erectile dysfunction.
    Tsao CW; Lee SS; Meng E; Wu ST; Chuang FP; Yu DS; Chang SY; Sun GH
    Arch Androl; 2004; 50(3):151-4. PubMed ID: 15204680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between diabetes mellitus, impotence and veno-occlusive dysfunction in Peyronie's disease patients.
    Culha M; Alici B; Acar O; Mutlu N; Gökalp A
    Urol Int; 1998; 60(2):101-4. PubMed ID: 9563148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between intrapenile O2 lever and quantity of intracavernous smooth muscle fibers: current physiopathological concept].
    Sattar AA; Salpigidis G; Schulman CC; Wespes E
    Acta Urol Belg; 1995 Mar; 63(1):53-9. PubMed ID: 7725993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study.
    Pescatori ES; Hatzichristou DG; Namburi S; Goldstein I
    J Urol; 1994 May; 151(5):1209-16. PubMed ID: 7512655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.